← All companies

INSM

Insmed Incorporated

INSM Nasdaq Pharmaceutical Preparations EDGAR ↗

$98.45

-3.04 -3.00%

Key statistics

from XBRL data in SEC filings

Market cap

$21.3B

Revenue (TTM)

$820M

Net income (TTM)

-$1.18B

EPS (TTM)

$-5.76

P/E ratio

—

Dividend yield

—

Free cash flow

-$968M

Cash

$582M

Total assets

$2.08B

Gross margin

16.0%

52-week range

$90.39 – $212.75

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jul 16, 2026 8-K Shareholder vote results May 15, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Regulation FD disclosure; Other events Apr 7, 2026 8-K Regulation FD disclosure; Other events Mar 23, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Results of operations (earnings release); Director or officer change Feb 19, 2026 8-K Regulation FD disclosure Jan 9, 2026 8-K Regulation FD disclosure; Other events Dec 17, 2025 8-K Regulation FD disclosure; Other events Nov 18, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Regulation FD disclosure; Other events Aug 12, 2025 8-K Results of operations (earnings release) Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Regulation FD disclosure; Other events Jun 13, 2025 8-K Regulation FD disclosure; Other events Jun 10, 2025 8-K Other events Jun 6, 2025 8-K Director or officer change; Shareholder vote results May 16, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K/A Other events Apr 24, 2025 8-K Other events Apr 24, 2025 8-K Director or officer change Apr 17, 2025 8-K Regulation FD disclosure; Other events Feb 24, 2025 8-K Results of operations (earnings release); Director or officer change Feb 20, 2025 10-K Fiscal year ended 2024-12-31 Feb 20, 2025 8-K Regulation FD disclosure; Other events Feb 6, 2025 8-K Regulation FD disclosure Jan 10, 2025 8-K Terminated a material agreement Nov 19, 2024 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation Oct 31, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Other events Aug 9, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Regulation FD disclosure Jul 3, 2024 8-K Other events Jun 27, 2024 8-K Other events Jun 13, 2024 8-K Regulation FD disclosure Jun 4, 2024